Business Trends– category –
-
Avantium Partners with Sojitz Pla-Net to Propel Plant-Based PEF “releaf®” Adoption in Japanese Market
Avantium N.V. (Press Release) Netherlands Overview Avantium N.V. announced a strategic partnership with Sojitz Pla-Net Corporation on September 8, 2026, to accelerate the adoption of its innovative plant-based polymers, FDCA and PEF (bra... -
Quantum Motion Secures Further Series C Investment to Accelerate Scalable Silicon Quantum Computing, Initiates U.S. Expansion
Quantum Motion UK Overview Quantum Motion, a UK leader in silicon spin-based quantum computing, announced a second close of its Series C funding round to accelerate the scaling of fault-tolerant quantum hardware. This additional capital ... -
Singapore Commits S$300 Million in National Quantum Strategy: Driving Quantum Processor Development via Neutral Atom Arrays, Trapped Ions, and Photonics
EDB Singapore Singapore Overview Singapore will invest approximately S$300 million over the next five years in quantum technology research and talent development through its National Quantum Strategy (NQS). This initiative includes the N... -
Sweden Unveils Inaugural National Quantum Strategy, Eyes Global Leadership by 2036
The Quantum Daily Sweden Overview Sweden has unveiled its first national quantum technology strategy, a long-term plan through 2036 aiming for global leadership in the field. Spearheaded by the Ministry of Education and Research, the str... -
Panasonic & CiRA Foundation Partner to Automate iPSC Manufacturing, Targeting High-Quality, Cost-Effective Therapies
Facebook (Panasonic Stories in 60 sec) Japan Overview Panasonic Holdings has announced a partnership with the CiRA Foundation to establish an automated, closed process for the efficient cultivation and large-scale manufacturing of high-q... -
Transcenta Therapeutics and WuXi Biologics Forge Strategic Alliance to Expedite Commercialization of HiCB Continuous Bioprocessing Technologies
BioSpace USA Overview Transcenta Therapeutics and WuXi Biologics have entered a strategic collaboration to accelerate the commercialization and deployment of Transcenta's proprietary High-Intensity Continuous Bioprocessing (HiCB) platfor... -
Defined Media for Pluripotent Stem Cell Maintenance Delivers Consistent Cell Quality and Medium Performance via Serum-Free, Xeno-Free, and Feeder-Free Approaches
Cellbase USA Overview The critical role of "defined media" for pluripotent stem cell (PSC) maintenance is highlighted, detailing how serum-free, chemically defined, xeno-free, feeder-free, and animal-component-free approaches contribute ... -
Samsung Biologics Inks $262M Manufacturing Deal with European Pharma, Propelling Songdo Expansion and Exceeding $21.9 Billion in Cumulative Contracts
BioProcess International USA Overview Samsung Biologics has announced a $262 million manufacturing contract with a European pharmaceutical company, extending through the end of 2033. Production will occur at the company’s manufacturing b... -
Australia’s VVMF Sydney Facility Secures TGA GMP License for Gene and Cell Therapy Manufacturing, Bolstering Domestic CDMO Capacity
Contract Pharma USA Overview Australia's Viral Vector Manufacturing Facility (VVMF) has officially received a Therapeutic Goods Administration (TGA) GMP license for therapeutic product manufacturing at its Sydney site, effective Septembe... -
iPSC Therapies: Manufacturing Consistency Requires Preserving Cell Functionality Beyond Basic Properties, Integrating Cell Line Selection and Genetic Engineering
Pharma's Almanac USA Overview An article in Pharma's Almanac highlights that iPSC-derived cardiomyocyte products, even with similar identity and purity, can exhibit differing functional performance, emphasizing the critical need to chara...
